Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502322 | SCV000593376 | likely benign | not specified | 2015-10-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311813 | SCV000846545 | likely benign | Inborn genetic diseases | 2016-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001311752 | SCV001502051 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | ARID1B: BP4, BP7 |
Gene |
RCV001311752 | SCV001855448 | benign | not provided | 2018-12-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807265 | SCV002054217 | benign | Coffin-Siris syndrome 1 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001311752 | SCV002449325 | likely benign | not provided | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001311752 | SCV005226196 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000502322 | SCV001956662 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001311752 | SCV001968048 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004535581 | SCV004754560 | benign | ARID1B-related disorder | 2019-07-02 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |